Indications and usage
Lynparza capsules are indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete response or partial response) to platinum-based chemotherapy.2
For full prescribing information please refer here.
Choose a maintenance treatment with…1–6
About the studies
The rationale for the use of Lynparza in platinum-sensitive relapsed ovarian cancer is based on data collected from two randomised, placebo-controlled, double blinded studies: Study 19 and SOLO2.3,4